Nancy Hong

Nancy Hong

Direktör/Styrelseledamot på
Sequre Dx, Inc.
Health Technology
Finance
Consumer Services

Profil

Dr. Nancy A. Hong is on the Board of Directors at Biolinq, Inc., Bluejay Therapeutics, Inc., Sequre Dx, Inc., Xilio Therapeutics LLC and Scout Bio, Inc. Dr. Hong was previously employed as a Managing Director by RiverVest Venture Management LLC, a Senior Associate by BioMed Ventures, a Principal by Novartis Institute for Functional Genomics, Inc., a Senior Analyst by Forward Ventures Services LLC, a Founder by Phenomix Corp., and a President by Archmont Biopharma, Inc. She also served on the board at Xilio Therapeutics, Inc. She received her undergraduate degree from California Institute of Technology and a doctorate degree from the University of California, Berkeley.

Aktiva positioner av Nancy Hong

FöretagPositionStart
Direktör/Styrelseledamot 2021-04-01
Direktör/Styrelseledamot 2021-09-01
Direktör/Styrelseledamot 2020-03-02
Direktör/Styrelseledamot 2021-06-01
Direktör/Styrelseledamot 2019-04-01

Tidigare kända positioner av Nancy Hong

FöretagPositionSlut
Privat kapitalinvesterare 2023-09-01
Företagsledare/Principal 2009-12-31
Private Equity-analytiker 2008-12-31
Företagsledare/Principal 2006-09-30
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ -
Se detaljerna i Nancy Hongs erfarenhet

Nancy Hongs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

19

Första gradens relationer

14

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag14

Health Technology

Finance

Consumer Services

Consumer Services

Finance

Commercial Services

Finance

Health Technology

Electronic Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Nancy Hong